Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antifibrinolytic Agents | 20 | 2023 | 249 | 7.440 |
Why?
|
| Tranexamic Acid | 15 | 2022 | 138 | 5.630 |
Why?
|
| Blood Loss, Surgical | 23 | 2022 | 648 | 5.230 |
Why?
|
| Craniosynostoses | 18 | 2022 | 390 | 4.450 |
Why?
|
| Blood Transfusion | 23 | 2023 | 1273 | 3.870 |
Why?
|
| Anemia | 18 | 2023 | 1466 | 3.640 |
Why?
|
| Erythrocyte Transfusion | 10 | 2023 | 551 | 1.940 |
Why?
|
| Postoperative Hemorrhage | 5 | 2019 | 398 | 1.600 |
Why?
|
| Hemostatics | 4 | 2022 | 225 | 1.260 |
Why?
|
| Perioperative Care | 7 | 2022 | 1056 | 1.230 |
Why?
|
| Blood Component Transfusion | 7 | 2022 | 139 | 1.090 |
Why?
|
| Scoliosis | 3 | 2020 | 705 | 1.010 |
Why?
|
| Postoperative Complications | 12 | 2019 | 15019 | 0.990 |
Why?
|
| Craniotomy | 4 | 2019 | 730 | 0.990 |
Why?
|
| Pediatrics | 6 | 2023 | 3441 | 0.980 |
Why?
|
| Craniofacial Abnormalities | 3 | 2018 | 317 | 0.930 |
Why?
|
| Intraoperative Complications | 5 | 2018 | 1182 | 0.900 |
Why?
|
| Surgical Procedures, Operative | 5 | 2019 | 1877 | 0.890 |
Why?
|
| Angiofibroma | 1 | 2023 | 65 | 0.880 |
Why?
|
| Blood Safety | 1 | 2020 | 11 | 0.780 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 281 | 0.750 |
Why?
|
| Oximetry | 1 | 2023 | 466 | 0.750 |
Why?
|
| Hemorrhage | 10 | 2023 | 3354 | 0.730 |
Why?
|
| Child | 44 | 2023 | 75163 | 0.710 |
Why?
|
| Clonidine | 1 | 2019 | 163 | 0.690 |
Why?
|
| Colorectal Surgery | 1 | 2021 | 127 | 0.680 |
Why?
|
| Standard of Care | 1 | 2022 | 531 | 0.670 |
Why?
|
| Thrombelastography | 5 | 2017 | 158 | 0.670 |
Why?
|
| Hematocrit | 2 | 2017 | 633 | 0.670 |
Why?
|
| Kyphosis | 1 | 2020 | 220 | 0.660 |
Why?
|
| Endoscopy | 4 | 2023 | 1757 | 0.600 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2016 | 2 | 0.590 |
Why?
|
| Cephalosporins | 1 | 2017 | 205 | 0.580 |
Why?
|
| Spinal Fusion | 3 | 2020 | 1211 | 0.570 |
Why?
|
| Fibrinolysis | 2 | 2015 | 331 | 0.560 |
Why?
|
| Neurosurgical Procedures | 3 | 2015 | 1995 | 0.550 |
Why?
|
| Infant | 32 | 2022 | 34337 | 0.540 |
Why?
|
| Acute Lung Injury | 2 | 2016 | 371 | 0.530 |
Why?
|
| Skull | 3 | 2020 | 808 | 0.490 |
Why?
|
| Aprotinin | 1 | 2014 | 88 | 0.480 |
Why?
|
| Hospital Mortality | 3 | 2016 | 5226 | 0.450 |
Why?
|
| Perioperative Period | 3 | 2023 | 261 | 0.440 |
Why?
|
| Child, Preschool | 24 | 2021 | 40440 | 0.410 |
Why?
|
| Length of Stay | 8 | 2022 | 6234 | 0.410 |
Why?
|
| Humans | 81 | 2023 | 725187 | 0.410 |
Why?
|
| Critical Illness | 7 | 2022 | 2597 | 0.410 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 659 | 0.400 |
Why?
|
| Developing Countries | 1 | 2023 | 2737 | 0.390 |
Why?
|
| Medical Records | 1 | 2016 | 1416 | 0.390 |
Why?
|
| Platelet Transfusion | 6 | 2022 | 298 | 0.390 |
Why?
|
| Liver Transplantation | 2 | 2022 | 2147 | 0.370 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 3487 | 0.370 |
Why?
|
| Blood Platelets | 1 | 2020 | 2457 | 0.360 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 1145 | 0.340 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2455 | 0.330 |
Why?
|
| Spine | 1 | 2015 | 1108 | 0.330 |
Why?
|
| Infant, Newborn | 13 | 2023 | 24985 | 0.330 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3111 | 0.320 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3221 | 0.320 |
Why?
|
| Plasma | 5 | 2022 | 564 | 0.320 |
Why?
|
| Gene Duplication | 1 | 2009 | 330 | 0.310 |
Why?
|
| Hemostasis | 2 | 2018 | 446 | 0.310 |
Why?
|
| Critical Care | 9 | 2022 | 2580 | 0.300 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 460 | 0.300 |
Why?
|
| Pandemics | 3 | 2020 | 7851 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2020 | 10971 | 0.280 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1592 | 0.280 |
Why?
|
| Treatment Outcome | 15 | 2019 | 61761 | 0.260 |
Why?
|
| Anesthesia | 1 | 2016 | 1561 | 0.250 |
Why?
|
| Laryngeal Masks | 1 | 2005 | 92 | 0.250 |
Why?
|
| Genetic Linkage | 2 | 2001 | 2443 | 0.250 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2016 | 136 | 0.250 |
Why?
|
| Adolescent | 17 | 2023 | 84401 | 0.250 |
Why?
|
| Gene Dosage | 1 | 2009 | 1266 | 0.250 |
Why?
|
| Hemoglobins | 2 | 2022 | 1518 | 0.240 |
Why?
|
| Prone Position | 1 | 2005 | 190 | 0.240 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 1264 | 0.240 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2001 | 76 | 0.230 |
Why?
|
| Male | 37 | 2023 | 347096 | 0.220 |
Why?
|
| General Surgery | 1 | 2014 | 1614 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7254 | 0.220 |
Why?
|
| Double-Blind Method | 4 | 2020 | 11883 | 0.210 |
Why?
|
| Female | 38 | 2021 | 375449 | 0.210 |
Why?
|
| Blood Donors | 2 | 2020 | 354 | 0.200 |
Why?
|
| Anesthesia, Epidural | 1 | 2003 | 238 | 0.200 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2022 | 189 | 0.200 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 14974 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7840 | 0.190 |
Why?
|
| Propensity Score | 2 | 2018 | 1755 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2001 | 321 | 0.190 |
Why?
|
| Erythrocyte Count | 1 | 2020 | 165 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2022 | 169 | 0.190 |
Why?
|
| Centromere | 1 | 2001 | 211 | 0.190 |
Why?
|
| Blood Banks | 1 | 2020 | 112 | 0.180 |
Why?
|
| Registries | 5 | 2019 | 7898 | 0.180 |
Why?
|
| Retrospective Studies | 13 | 2019 | 74206 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 6994 | 0.180 |
Why?
|
| Bone Marrow Diseases | 1 | 2001 | 232 | 0.170 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2019 | 88 | 0.170 |
Why?
|
| Hematologic Diseases | 2 | 2000 | 493 | 0.170 |
Why?
|
| Adsorption | 1 | 2019 | 207 | 0.170 |
Why?
|
| Intraoperative Care | 2 | 2013 | 760 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 379 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2023 | 1831 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1999 | 457 | 0.160 |
Why?
|
| Hemodilution | 2 | 2018 | 113 | 0.150 |
Why?
|
| Hematinics | 2 | 2018 | 280 | 0.150 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3621 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 609 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2017 | 7683 | 0.150 |
Why?
|
| Risk Factors | 11 | 2019 | 71009 | 0.150 |
Why?
|
| Half-Life | 1 | 2017 | 668 | 0.140 |
Why?
|
| Hypovolemia | 1 | 2016 | 43 | 0.140 |
Why?
|
| Prospective Studies | 9 | 2021 | 51869 | 0.140 |
Why?
|
| Models, Biological | 1 | 2013 | 9669 | 0.140 |
Why?
|
| Monitoring, Physiologic | 1 | 2023 | 1739 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2017 | 363 | 0.130 |
Why?
|
| Blood Gas Analysis | 2 | 2014 | 386 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 464 | 0.130 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 567 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2014 | 41 | 0.130 |
Why?
|
| Platelet Count | 1 | 2017 | 785 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2021 | 984 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2260 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2020 | 1488 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 975 | 0.120 |
Why?
|
| Papilloma | 1 | 2014 | 149 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 1419 | 0.120 |
Why?
|
| Blood Substitutes | 1 | 2013 | 60 | 0.110 |
Why?
|
| Fibrinogen | 1 | 2016 | 897 | 0.110 |
Why?
|
| Incidence | 4 | 2019 | 20750 | 0.110 |
Why?
|
| Iron | 1 | 2021 | 1714 | 0.110 |
Why?
|
| Pancreas | 1 | 1999 | 1657 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 957 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1879 | 0.100 |
Why?
|
| Analgesics | 1 | 2019 | 1052 | 0.100 |
Why?
|
| Airway Management | 1 | 2015 | 302 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2020 | 2265 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2017 | 946 | 0.100 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2013 | 154 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2020 | 2425 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1138 | 0.100 |
Why?
|
| Hypotension | 1 | 2016 | 838 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1848 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2018 | 23185 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3511 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2222 | 0.090 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 2391 | 0.090 |
Why?
|
| Lod Score | 2 | 2001 | 622 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1504 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 1481 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2016 | 4446 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2016 | 9839 | 0.080 |
Why?
|
| Bone and Bones | 1 | 1999 | 2565 | 0.080 |
Why?
|
| Erythropoietin | 1 | 2013 | 723 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1301 | 0.080 |
Why?
|
| Sepsis | 1 | 2022 | 2504 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2019 | 39918 | 0.080 |
Why?
|
| Blood Coagulation Disorders | 2 | 2020 | 335 | 0.080 |
Why?
|
| Genes, Recessive | 2 | 2001 | 649 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2013 | 1126 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 2015 | 1145 | 0.080 |
Why?
|
| United States | 6 | 2021 | 68403 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2019 | 2540 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17354 | 0.080 |
Why?
|
| Logistic Models | 3 | 2019 | 13358 | 0.070 |
Why?
|
| Cross Infection | 1 | 2016 | 1405 | 0.070 |
Why?
|
| Emergencies | 2 | 2020 | 1135 | 0.070 |
Why?
|
| Intensive Care Units | 2 | 2019 | 3584 | 0.070 |
Why?
|
| Syndrome | 3 | 2001 | 3223 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4938 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13698 | 0.060 |
Why?
|
| Thiopental | 1 | 2002 | 59 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3545 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12249 | 0.060 |
Why?
|
| Epidural Space | 1 | 2003 | 125 | 0.060 |
Why?
|
| Pedigree | 2 | 2001 | 4647 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1404 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15442 | 0.050 |
Why?
|
| Algorithms | 3 | 2018 | 13765 | 0.050 |
Why?
|
| Age Factors | 4 | 2019 | 18339 | 0.050 |
Why?
|
| Operative Blood Salvage | 1 | 2020 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19624 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2001 | 737 | 0.050 |
Why?
|
| Time Factors | 3 | 2019 | 40186 | 0.050 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2001 | 92 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 1442 | 0.050 |
Why?
|
| Platelet Function Tests | 1 | 2001 | 271 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2001 | 3502 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 1387 | 0.050 |
Why?
|
| Italy | 1 | 2021 | 818 | 0.040 |
Why?
|
| Anesthetics, Intravenous | 1 | 2002 | 409 | 0.040 |
Why?
|
| Prevalence | 1 | 2016 | 14992 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 59 | 0.040 |
Why?
|
| Coagulants | 1 | 2018 | 49 | 0.040 |
Why?
|
| Neonatology | 1 | 2020 | 110 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21591 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2003 | 1761 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5082 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9588 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 732 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 548 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2020 | 3706 | 0.040 |
Why?
|
| Propofol | 1 | 2002 | 613 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 1989 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2001 | 795 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 825 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1113 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 499 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 604 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2001 | 979 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2022 | 827 | 0.030 |
Why?
|
| Craniofacial Dysostosis | 1 | 2014 | 73 | 0.030 |
Why?
|
| Gastroenterology | 1 | 2020 | 505 | 0.030 |
Why?
|
| Haplotypes | 1 | 2001 | 2782 | 0.030 |
Why?
|
| Reoperation | 2 | 2017 | 4158 | 0.030 |
Why?
|
| Acrocephalosyndactylia | 1 | 2014 | 87 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 962 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2001 | 3593 | 0.030 |
Why?
|
| Mutation | 2 | 2013 | 29672 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 1061 | 0.030 |
Why?
|
| North America | 1 | 2017 | 1208 | 0.030 |
Why?
|
| Research | 1 | 2022 | 2013 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 959 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20941 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 404 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 568 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1999 | 2653 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4758 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2821 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2013 | 255 | 0.020 |
Why?
|
| Embolism, Air | 1 | 2010 | 109 | 0.020 |
Why?
|
| Seizures | 1 | 2022 | 2745 | 0.020 |
Why?
|
| Alleles | 1 | 2001 | 6952 | 0.020 |
Why?
|
| Adult | 4 | 2019 | 211615 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2014 | 637 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1264 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 757 | 0.020 |
Why?
|
| Pain | 1 | 2002 | 4830 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6554 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1717 | 0.020 |
Why?
|
| Software | 1 | 2001 | 4406 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 720 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 4940 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2018 | 4425 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8104 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12817 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14721 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 55781 | 0.010 |
Why?
|
| Trypsinogen | 1 | 2000 | 85 | 0.010 |
Why?
|
| Paternal Age | 1 | 2000 | 84 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6537 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 9964 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1563 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13157 | 0.010 |
Why?
|
| Boston | 1 | 2010 | 9288 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2002 | 1924 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 28737 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 1286 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 11968 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 38748 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 2825 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2000 | 6163 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16272 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 161486 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 212292 | 0.000 |
Why?
|
Concepts
(266)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_